The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
National US Estimates of Recombinant Tissue Plasminogen Activator Use: ICD-9 Codes Substantially Underestimate
Open accessAbstract
Background and Purpose— Current US estimates of recombinant tissue plasminogen activator (rt-PA) use have been based either on extrapolation of regional studies or on administrative database estimates, both of which may have inherent biases. We sought to compare the utilization of rt-PA in acute ischemic stroke in the MEDPAR database to another national hospital database with drug utilization information. Methods— Cases were defined as DRG 14,15, and 524 and ICD-9 code 99.1, which indicates cerebral thrombolysis, for fiscal year 2001 to 2004. Additionally, the Premier database was queried for rt-PA utilization documented in pharmacy records in those patients admitted for stroke. Change over time and difference between databases were tested using Poisson regression. Results— When comparing databases, rt-PA use, as identified by ICD-9 code 99.1, was only documented in 0.95% of stroke cases in 2004 in MEDPAR, and 1.2% in the Premier database, which slightly increased by 0.04% to 0.09% over time. Analysis of pharmacy billing records increased the estimate to 1.82%. Exclusion of cases younger than 65years excluded 43% of cases treated with rt-PA. In 2004, 12.7% of cases receiving thrombolytic had either a TIA or a hemorrhagic stroke ICD-9 code. Conclusions— We estimate the rate of rt-PA use in the United States to be 1.8% to 2.1% of ischemic stroke patients. The rate of thrombolytic use for ischemic stroke was slightly increasing between 2001 and 2004 at a rate of 0.04% to 0.09% per year. A significant proportion of patients treated with rt-PA are likely miscoded as either TIA or hemorrhagic stroke. We conservatively estimate that 10 800 to 12 600 patients received rt-PA in 2004.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and procedures of statistics.
Steel, R. G. D., & Torrie, J. H. (1960) · Cited by 24,135
Principles and Procedures of Statistics: A Biometrical Approach
Steel, R. G. D., & Torrie, J. H. (1980) · Andalas University Repository (Andalas University) · Cited by 15,510
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
The Paul Coverdell Prototype Registries Writing Group* (2005) · Stroke · doi:10.1161/01.str.0000165902.18021.5b · Cited by 407
Chiu, D., Krieger, D., Villar-Cordova, C., Kasner, S. E., Morgenstern, L. B., Bratina, P. L., Yatsu, F. M., & Grotta, J. C. (1998) · Stroke · doi:10.1161/01.str.29.1.18 · Cited by 406
Kleindorfer, D., Kissela, B., Schneider, A., Woo, D., Khoury, J., Miller, R., Alwell, K., Gebel, J., Szaflarski, J., Pancioli, A., et al. (2004) · Stroke · doi:10.1161/01.str.0000109767.11426.17 · Cited by 299
Self-citationUtilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Katzan, I. L., Hammer, M. D., Hixson, E. D., Furlan, A. J., Abou-Chebl, A., & Nadzam, D. M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.346 · Cited by 289
Grotta, J. C., Burgin, W. S., El-Mitwalli, A., Long, M., Campbell, M., Morgenstern, L. B., Malkoff, M., & Alexandrov, A. V. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.2009 · Cited by 233
Gilligan, A. K., Thrift, A. G., Sturm, J. W., Dewey, H. M., Macdonell, R. A. L., & Donnan, G. A. (2005) · Cerebrovascular Diseases · doi:10.1159/000087705 · Cited by 104
Cited by
Adeoye, O., Hornung, R., Khatri, P., & Kleindorfer, D. (2011) · Stroke · doi:10.1161/strokeaha.110.612358 · Cited by 474
Self-citationTherapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Pathogenesis of acute stroke and the role of inflammasomes
Fann, D. Y.-W., Lee, S.-Y., Manzanero, S., Chunduri, P., Sobey, C. G., & Arumugam, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.09.004 · Cited by 335
Sex differences in stroke: Challenges and opportunities
Bushnell, C. D., Chaturvedi, S., Gage, K. R., Herson, P. S., Hurn, P. D., Jiménez, M. C., Kittner, S. J., Madsen, T. E., McCullough, L. D., McDermott, M., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18793324 · Cited by 305
Macrae, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01398.x · Cited by 274
Metadata
- Authors
- Kleindorfer, D., Lindsell, C. J., Brass, L., Koroshetz, W., & Broderick, J. P.
- Venue
- Stroke
- Published
- 2008-03
- Volume
- 39
- Issue
- 3
- Pages
- 924-928
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2168831392
- Cited by
- 274
- References
- 12
- FWCI
- 20.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: National US Estimates of Recombinant Tissue Plasminogen Activator Use: ICD-9 Codes Substantially Underestimate. https://app.cochat.ai/papers/10.1161/strokeaha.107.490375
- The paper
- Kleindorfer, D., Lindsell, C. J., Brass, L., Koroshetz, W., & Broderick, J. P. (2008). National US Estimates of Recombinant Tissue Plasminogen Activator Use: ICD-9 Codes Substantially Underestimate. Stroke. https://doi.org/10.1161/strokeaha.107.490375
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.